Cleerly LABS vs ZEUS System

Cleerly LABS offers a rich diagnostic user experience with an interactive, web-based interface and 3D visualization for complex CCTA data, providing clear, actionable clinical insights. Its ability to integrate with existing PACS, RIS, and EHR systems, along with multiple data upload methods and rapid processing times, streamlines clinical workflows. While ZEUS System also provides a web portal and mobile app for workflow management, Cleerly's advanced visualization for intricate imaging data gives it an edge in interpreting complex cardiac conditions.

Both tools are FDA-cleared and demonstrate strong clinical value in their respective areas. Cleerly LABS provides comprehensive AI-driven quantification and characterization of coronary plaque, stenosis, and ischemia from CCTA, with evidence showing a reduction in heart attacks and increased diagnostic confidence. This detailed, proactive assessment of coronary artery disease, a leading cause of death, offers a potentially broader and more impactful clinical utility for preventative care compared to ZEUS System's arrhythmia detection.

Cleerly LABS offers transparent pricing per analysis, with a retail price and a discounted rate, and growing insurance coverage from major payors like Aetna, UnitedHealthcare, and Medicare. In contrast, the ZEUS System's pricing is not disclosed, making it difficult to assess its financial value directly. The transparency and increasing coverage for Cleerly provide a clearer understanding of its cost and accessibility for providers and patients.

Both tools are cloud-based, FDA-cleared, HIPAA compliant, and have BAAs, indicating strong enterprise readiness. Cleerly LABS explicitly details integration with PACS, RIS, and EHR via its on-site proxy, which is critical for imaging-centric workflows, and supports various data upload methods for seamless integration into hospital systems. While ZEUS System offers HL7-based EHR integration, Cleerly's specific focus on comprehensive imaging system integration provides a slight advantage in complex radiology and cardiology environments.

Cleerly LABS demonstrates a more disruptive innovation by moving beyond traditional stenosis assessment to provide comprehensive AI-driven quantification and characterization of coronary plaque (volume, type) from CCTA, aiming to establish a new standard of care for heart attack prevention [JSON, cite: 15]. While ZEUS System's AI-powered continuous ECG monitoring via wearables is innovative, Cleerly's deep and granular analysis of plaque morphology represents a more significant advancement in understanding and managing cardiovascular disease proactively.

iRhythm (ZEUS System) provides more comprehensive support, including a dedicated billing team available 24/7/365, and offers customer care via both phone and email. Cleerly's support is available during more limited business hours (Monday-Friday, 10 am ET to 6 pm ET). The 24/7/365 availability of a specialized billing team for iRhythm indicates a higher level of continuous support for critical administrative functions.